Rafferty Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-39,251
| Closed | -$2.95M | – | 1292 |
|
|
2022
Q2 | $2.95M | Sell |
39,251
-153,875
| -80% | -$11.6M | 0.03% | 397 |
|
|
2022
Q1 | $5.19M | Buy |
193,126
+58,489
| +43% | +$1.57M | 0.03% | 383 |
|
|
2021
Q4 | $6.42M | Buy |
134,637
+91,821
| +214% | +$4.38M | 0.03% | 284 |
|
|
2021
Q3 | $2.84M | Buy |
42,816
+8,000
| +23% | +$531K | 0.02% | 511 |
|
|
2021
Q2 | $2.72M | Buy |
34,816
+5,758
| +20% | +$449K | 0.02% | 542 |
|
|
2021
Q1 | $2.75M | Buy |
29,058
+21,199
| +270% | +$2.01M | 0.02% | 542 |
|
|
2020
Q4 | $958K | Sell |
7,859
-17,350
| -69% | -$2.11M | 0.01% | 510 |
|
|
2020
Q3 | $2.2M | Buy |
25,209
+15,116
| +150% | +$1.32M | 0.03% | 386 |
|
|
2020
Q2 | $652K | Buy |
+10,093
| New | +$652K | 0.01% | 646 |
|
|
2020
Q1 | – | Sell |
-27,392
| Closed | -$1.71M | – | 854 |
|
|
2019
Q4 | $1.71M | Buy |
27,392
+2,211
| +9% | +$138K | 0.03% | 435 |
|
|
2019
Q3 | $947K | Buy |
+25,181
| New | +$947K | 0.01% | 554 |
|